Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Aurora Spine is a medical technology company focused on the development and commercialization of innovative, minimally invasive regenerative spinal implant technologies. The company's product portfolio includes the ZIP series of minimally invasive interspinous fixation devices and the DEXA platform, which features bone-mimicking implants tailored to a patient's specific bone density. Aurora Spine aims to improve patient outcomes by providing surgeons with advanced tools for spinal fusion and stabilization. Their solutions address common spinal conditions such as degenerative disc disease and spinal stenosis. The company is headquartered in Carlsbad, California, and is publicly traded on the TSX Venture Exchange.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Aurora Spine.